Cardiff Oncology, Inc. (CRDF) Financials
CRDF Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 88.5 million | 10.6 million |
2023-06-30 | 97.5 million | 10.9 million |
2023-03-31 | 106.5 million | 10.0 million |
2022-12-31 | 116.2 million | 9.8 million |
CRDF Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.3 million | 955000 |
2023-06-30 | -7.4 million | 1.6 million |
2023-03-31 | -8.7 million | 1.1 million |
2022-12-31 | -9.5 million | 1.0 million |
CRDF Net Income
No data available :(
CRDF Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 81.4 million | - | 2.3 million |
2023-06-30 | 89.4 million | - | 2.4 million |
2023-03-31 | 97.0 million | - | 2.6 million |
2022-12-31 | 105.3 million | - | 2.7 million |
CRDF Shares Outstanding
CRDF Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 315000 | 8.0 million | 2.9 million | - |
2023-06-30 | 251000 | 8.0 million | 4.3 million | - |
2023-03-31 | 8000 | 9.1 million | 3.1 million | - |
2022-12-31 | 75000 | 6.4 million | 3.1 million | - |
CRDF Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 141000 | - |
2023-06-30 | 108000 | - |
2023-03-31 | 83000 | - |
2022-12-31 | 128000 | - |
CRDF
Price: $4.07
52 week price:
Earnings Per Share: -0.93 USD
P/E Ratio: -1.97
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 531000
Market Capitalization: 252.9 million